X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (307) 307
female (247) 247
male (231) 231
index medicus (224) 224
lung neoplasms - ethnology (217) 217
middle aged (206) 206
carcinoma, non-small-cell lung - ethnology (199) 199
aged (195) 195
oncology (170) 170
adult (129) 129
lung neoplasms - genetics (110) 110
lung cancer (106) 106
carcinoma, non-small-cell lung - genetics (97) 97
cancer (91) 91
aged, 80 and over (88) 88
lung neoplasms - pathology (80) 80
risk factors (75) 75
carcinoma, non-small-cell lung - pathology (73) 73
asian continental ancestry group - genetics (70) 70
prognosis (68) 68
lung neoplasms - drug therapy (65) 65
survival (65) 65
lung cancer, non-small cell (64) 64
polymorphism, single nucleotide (62) 62
carcinoma, non-small-cell lung - drug therapy (61) 61
case-control studies (59) 59
carcinoma (58) 58
lung neoplasms - mortality (58) 58
research (57) 57
carcinoma, non-small-cell lung - mortality (56) 56
respiratory system (56) 56
genetic aspects (54) 54
genotype (53) 53
neoplasm staging (53) 53
mutation (50) 50
risk (50) 50
asian continental ancestry group (49) 49
genetic predisposition to disease (47) 47
polymorphism (47) 47
retrospective studies (47) 47
adenocarcinoma - ethnology (46) 46
chemotherapy (46) 46
non-small cell lung cancer (45) 45
smoking (45) 45
china (44) 44
gefitinib (43) 43
treatment outcome (43) 43
expression (41) 41
gene frequency (41) 41
article (38) 38
care and treatment (38) 38
analysis (37) 37
epidemiology (37) 37
research article (37) 37
antineoplastic agents - therapeutic use (36) 36
adenocarcinoma (34) 34
european continental ancestry group - genetics (33) 33
genes (33) 33
health aspects (33) 33
medicine (33) 33
survival rate (33) 33
adenocarcinoma - genetics (32) 32
european continental ancestry group (32) 32
odds ratio (32) 32
survival analysis (32) 32
breast-cancer (31) 31
multidisciplinary sciences (31) 31
receptor, epidermal growth factor - genetics (31) 31
studies (29) 29
surgery (29) 29
abridged index medicus (28) 28
carcinoma, non-small-cell lung - therapy (28) 28
carcinoma, squamous cell - ethnology (28) 28
erlotinib (28) 28
genetic predisposition to disease - genetics (28) 28
lung neoplasms - therapy (28) 28
ethnicity (27) 27
medicine, general & internal (27) 27
science (27) 27
carcinoma, non-small-cell lung - surgery (26) 26
genetics (26) 26
lung neoplasms - surgery (26) 26
meta-analysis (26) 26
population (26) 26
race (26) 26
association (25) 25
mortality (25) 25
quinazolines - therapeutic use (25) 25
united states - epidemiology (25) 25
disease-free survival (24) 24
kaplan-meier estimate (24) 24
sex factors (24) 24
single nucleotide polymorphisms (24) 24
antineoplastic combined chemotherapy protocols - therapeutic use (23) 23
multivariate analysis (23) 23
proportional hazards models (23) 23
therapy (23) 23
alleles (22) 22
gene expression (22) 22
seer program (22) 22
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 2, pp. 213 - 222
Summary Background Afatinib—an oral irreversible ErbB family blocker—improves progression-free survival compared with pemetrexed and cisplatin for first-line... 
Hematology, Oncology and Palliative Medicine | GEFITINIB | MULTICENTER | SOLID TUMORS | ONCOLOGY | ADENOCARCINOMA | CLINICAL-TRIALS | INHIBITOR | ERBB FAMILY BLOCKER | CHEMOTHERAPY | ERLOTINIB | Lung Neoplasms - drug therapy | Lung Neoplasms - ethnology | Receptor, Epidermal Growth Factor - genetics | Lung Neoplasms - mortality | Humans | Middle Aged | Thailand - epidemiology | Asian Continental Ancestry Group - genetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Protein Kinase Inhibitors - adverse effects | Cisplatin - administration & dosage | Time Factors | Female | Odds Ratio | Republic of Korea - epidemiology | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Carcinoma, Non-Small-Cell Lung - genetics | Deoxycytidine - administration & dosage | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Carcinoma, Non-Small-Cell Lung - ethnology | Linear Models | Logistic Models | Treatment Outcome | China - epidemiology | Carcinoma, Non-Small-Cell Lung - mortality | Disease Progression | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Intention to Treat Analysis | Quinazolines - adverse effects | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Neoplasm Staging | Deoxycytidine - analogs & derivatives | Antimitotic agents | Medical colleges | Care and treatment | Chemotherapy | Product development | Lung cancer, Non-small cell | Antineoplastic agents | Tumors | Cancer | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2009, Volume 27, Issue 16, pp. 2653 - 2659
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2010, Volume 28, Issue 5, pp. 753 - 760
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2013, Volume 31, Issue 28, pp. 3572 - 3578
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2012, Volume 7, Issue 3, p. e33200
Purpose: Xeroderma pigmentosum group D (XPD) codes for a DNA helicase involved in nucleotide excision repair thatremoves platinum-induced DNA damage. Genetic... 
EXCISION-REPAIR | SURVIVAL | POPULATION | PROGNOSTIC-FACTORS | CISPLATIN | BIOLOGY | RISK | REPAIR GENE XPD | ASSOCIATION | CARCINOMA | SINGLE NUCLEOTIDE POLYMORPHISMS | Haplotypes | Lung Neoplasms - drug therapy | Lung Neoplasms - ethnology | Multivariate Analysis | Prognosis | Humans | Middle Aged | Asian Continental Ancestry Group - genetics | Male | Cisplatin - administration & dosage | China | Aged, 80 and over | Adult | Female | Lung Neoplasms - genetics | Xeroderma Pigmentosum Group D Protein - genetics | Drug Administration Schedule | Carcinoma, Non-Small-Cell Lung - genetics | Gene Frequency | Carboplatin - administration & dosage | Carcinoma, Non-Small-Cell Lung - ethnology | Genotype | Treatment Outcome | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Polymorphism, Single Nucleotide | Carcinoma, Non-Small-Cell Lung - drug therapy | Medical research | Care and treatment | Patient outcomes | DNA damage | Lung cancer, Small cell | Lung cancer, Non-small cell | DNA repair | Genetic polymorphisms | Chemotherapy | Ionization | Medicine, Experimental | Genetic aspects | Rankings | Mass spectrometry | Glutamine | Cancer | Adenocarcinoma | Disease | Laboratories | Lung cancer | Multiple myeloma | Xeroderma pigmentosum | Oncology | Epidemiology | Cancer therapies | Clinical outcomes | Skin cancer | DNA helicase | Platinum | XPD protein | Life sciences | Repair | Genotypes | Deoxyribonucleic acid--DNA | Melanoma | Non-small cell lung carcinoma | Nucleotide excision repair | Mass spectroscopy | Patients | Survival | Experimental design | Medical prognosis | Respiratory diseases | Influence | Genetic engineering | Genetic testing | Apoptosis | Deoxyribonucleic acid | DNA
Journal Article
Annals of Epidemiology, ISSN 1047-2797, 08/2018, Volume 28, Issue 8, pp. 543 - 548
Journal Article
Journal Article
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 07/2010, Volume 5, Issue 7, pp. 1001 - 1010
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2017, Volume 35, Issue 32, pp. 3662 - 3670
Journal Article
Cancer Science, ISSN 1347-9032, 06/2018, Volume 109, Issue 6, pp. 1930 - 1938
Journal Article